Eurobio Scientific Société anonyme

DB:E8TN Stock Report

Market Cap: €258.6m

Eurobio Scientific Société anonyme Balance Sheet Health

Financial Health criteria checks 6/6

Eurobio Scientific Société anonyme has a total shareholder equity of €178.8M and total debt of €88.2M, which brings its debt-to-equity ratio to 49.3%. Its total assets and total liabilities are €313.8M and €134.9M respectively. Eurobio Scientific Société anonyme's EBIT is €12.9M making its interest coverage ratio 4.3. It has cash and short-term investments of €86.6M.

Key information

49.3%

Debt to equity ratio

€88.17m

Debt

Interest coverage ratio4.3x
Cash€86.59m
Equity€178.83m
Total liabilities€134.94m
Total assets€313.77m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: E8TN's short term assets (€146.7M) exceed its short term liabilities (€54.5M).

Long Term Liabilities: E8TN's short term assets (€146.7M) exceed its long term liabilities (€80.4M).


Debt to Equity History and Analysis

Debt Level: E8TN's net debt to equity ratio (0.9%) is considered satisfactory.

Reducing Debt: E8TN's debt to equity ratio has reduced from 53.2% to 49.3% over the past 5 years.

Debt Coverage: E8TN's debt is well covered by operating cash flow (26.2%).

Interest Coverage: E8TN's interest payments on its debt are well covered by EBIT (4.3x coverage).


Balance Sheet


Discover healthy companies